SEPTInvestingStart Free

INBX SCHEDULE 13G/A: SEC filing

Schonfeld Strategic Advisors LLC

Filed with the SEC on · accession 0001193805-26-001466

INBX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -5.1% by the first close after the filing.

Summary of the filing

Schonfeld Strategic Advisors LLC filed an amended Schedule 13G reporting beneficial ownership of 952,959 shares (6.47%) of Inhibrx Biosciences common stock as of September 30, 2026, held passively through separately managed accounts.

For details, click here →

Key details

shares beneficially owned$953K
percent of class beneficially owned$6
shares outstanding as of August 7, 2026$14.7M
Reporting person / beneficial owner (investment adviser)Schonfeld Strategic Advisors LLC
IssuerInhibrx Biosciences, Inc.
Chief compliance officer, schonfeld strategic advisors llcHung Luc

How INBX stock reacted

Close before

$87.75

Nov 12, 2026

First close after

-5.07%

$83.30

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for INBX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INBX?

Click here

Frequently asked questions

What did INBX file with the SEC on Nov 13, 2026?

INBX filed a SCHEDULE 13G/A (SEC filing). Schonfeld Strategic Advisors LLC filed an amended Schedule 13G reporting beneficial ownership of 952,959 shares (6.47%) of Inhibrx Biosciences common stock as of September 30, 2026, held passively through separately managed accounts.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did INBX stock react to this filing?

INBX closed at $87.75 before the filing and $83.30 on Nov 13, 2026 (-5.07%).

Other INBX SEC filings

Get alerts when INBX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
INBX overviewINBX analysisINBX newsLatest SEC filings